Ocular Therapeutix™ to Present at the Jefferies London Healthcare Conference and Ophthalmology Innovation Summit XIV

2 days ago

BEDFORD, Mass., Nov. 13, 2024 ( GLOBE NEWSWIRE ) -- Ocular Therapeutix, Inc. ( NASDAQ: OCUL, "Ocular", the "Company" ) , a biopharmaceutical company committed to improving vision in the real world through the development and commercialization of innovative therapies for retinal diseases and ...

Ticker	Sentiment	Impact
OCUL	Bullish	68 %